• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: HOLOGIC, INC MYOSURE HYSTEROSCOPIC TISSUE REMOVAL SYSTEM; UTERINE TISSUE REMOVAL SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

HOLOGIC, INC MYOSURE HYSTEROSCOPIC TISSUE REMOVAL SYSTEM; UTERINE TISSUE REMOVAL SYSTEM Back to Search Results
Model Number 10-401
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Bacterial Infection (1735); Sepsis (2067)
Event Type  Injury  
Manufacturer Narrative
Lot number of the disposable device not provided by the complainant, therefore the expiration date is not known.The device is not being returned therefore, a failure analysis of the complaint device cannot be completed.If additional relevant information is received or device evaluation completed, a supplemental medwatch will be filed.Lot number of the disposable device not provided by the complainant, therefore the manufacture date is not known.Device history record (dhr) review was unable to be conducted for the disposable device as the identification numbers were not provided by the complainant.
 
Event Description
This is the first of two hologic reports related to this event.Please also refer to 1222780-2020-00022 for the second report.It was reported to hologic by the performing physician that in (b)(6) or (b)(6) of 2019, he had completed an uncomplicated fibroid removal procedure followed by an endometrial ablation.Both procedures were completed without incident.The physician stated "the patient went home with some discomfort however later on in the evening the patient was not feeling well." he suggested the patient go to the emergency department.The patient arrived that night at 1:00am and had blood work done with culture.The culture results were positive for strep and sepsis.The patient was monitored and prescribed medication.The patient had a laparoscopic procedure three days later to rule out any puss or infection in the abdomen."there were no findings of infection in the abdomen and all looked benign." a hysteroscopy was also performed and there was no signs of any puss or fluid build up in the uterine cavity.The physician stated the patient is doing very well and no signs of infection to report.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MYOSURE HYSTEROSCOPIC TISSUE REMOVAL SYSTEM
Type of Device
UTERINE TISSUE REMOVAL SYSTEM
Manufacturer (Section D)
HOLOGIC, INC
250 campus drive
marlborough MA 01752
Manufacturer Contact
kelsea lyver
250 campus drive
marlborough, MA 01752
5082636130
MDR Report Key9661942
MDR Text Key178125461
Report Number1222780-2020-00021
Device Sequence Number1
Product Code HIH
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K100559
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,user faci
Reporter Occupation Physician
Type of Report Initial
Report Date 01/16/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model Number10-401
Device Catalogue Number10-401
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 01/16/2020
Initial Date FDA Received02/03/2020
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Other; Required Intervention;
-
-